SARS-CoV-2, a new causal agent of Guillain-Barre syndrome
| Errataetall: |
CommentIn: Rev Neurol. 2020 Dec 1;71(11):430. - PMID 33205390 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
|---|---|
| Enthalten in: |
Revista de neurologia - 71(2020), 7 vom: 01. Okt., Seite 275-276 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
SARS-CoV-2, nuevo agente causal del síndrome de Guillain-Barré |
|---|
| Beteiligte Personen: |
Redondo-Urda, M J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 02.10.2020 Date Revised 18.12.2020 published: Print CommentIn: Rev Neurol. 2020 Dec 1;71(11):430. - PMID 33205390 Citation Status MEDLINE |
|---|
| doi: |
10.33588/rn.7107.2020264 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315305894 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315305894 | ||
| 003 | DE-627 | ||
| 005 | 20231225154625.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.33588/rn.7107.2020264 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1050.xml |
| 035 | |a (DE-627)NLM315305894 | ||
| 035 | |a (NLM)32959360 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Redondo-Urda, M J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2, a new causal agent of Guillain-Barre syndrome |
| 246 | 3 | 3 | |a SARS-CoV-2, nuevo agente causal del síndrome de Guillain-Barré |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.10.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Rev Neurol. 2020 Dec 1;71(11):430. - PMID 33205390 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 650 | 7 | |a Immunoglobulin M |2 NLM | |
| 700 | 1 | |a Rodríguez-Peguero, F J |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-Gil, O |e verfasserin |4 aut | |
| 700 | 1 | |a Del Valle-Sánchez, M |e verfasserin |4 aut | |
| 700 | 1 | |a Carrera-Izquierdo, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista de neurologia |d 1994 |g 71(2020), 7 vom: 01. Okt., Seite 275-276 |w (DE-627)NLM074738666 |x 1576-6578 |7 nnns |
| 773 | 1 | 8 | |g volume:71 |g year:2020 |g number:7 |g day:01 |g month:10 |g pages:275-276 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.33588/rn.7107.2020264 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 71 |j 2020 |e 7 |b 01 |c 10 |h 275-276 | ||